Archives
BODIPY 581/591 C11: Scope and Evidence
BODIPY 581/591 C11 is described by APExBIO as a cell-permeable, ratiometric fluorescent probe intended for lipid peroxidation detection and oxidative stress measurement in biological membranes or living cells. The product description identifies the compound as CAS 217075-36-0, with molecular formula C30H35BF2N2O2 and molecular weight 504.42. APExBIO’s product page is the relevant source for these identity and mechanism claims: BODIPY 581/591 C11.
The available evidence supports a proportionate interpretation of the material as an oxidation-responsive fluorescent reporter. It does not, by itself, constitute evidence that the product has been validated in a named disease model, cell type, animal study, or clinical setting. No identity-matched research paper with study-level outcomes is available in the cited material.
Documented identity and scientific context
The defining analytical feature reported for BODIPY 581/591 C11 is a change in fluorescence associated with oxidation of its polyunsaturated butadienyl segment. In the reduced state, the product description reports red fluorescence with excitation and emission maxima of approximately 581 and 591 nm. After oxidation, the described signal shifts toward the green region, with excitation and emission around 488 and 510 nm.
This design places the compound within a class of fluorescent lipid-associated reporters whose value is not simply that they fluoresce, but that the relationship between two spectral states can provide a ratiometric readout. In principle, a ratiometric signal can be interpreted as a relative change between reduced-like and oxidized-like probe populations rather than as a single absolute fluorescence intensity. That distinction matters because single-channel intensity can be influenced by factors unrelated to oxidation, including probe abundance, optical collection, cellular distribution, and other properties of the measurement context. The product description, however, does not provide a validation dataset quantifying how effectively ratiometry controls those influences.
APExBIO also describes BODIPY 581/591 C11 as cell-permeable, highly photostable, and characterized by a high quantum yield. These are documented product attributes, not independent comparative findings. The same source states that the material is supplied as a solid and gives storage and shipping information; those logistical details establish the supplier’s handling specification but do not provide evidence about biological performance.
Documented mechanism and measurement principle
The reported mechanism is an oxidation-linked spectral conversion. The reduced probe is associated with red fluorescence, whereas oxidation of the butadienyl segment is associated with a green-shifted signal. The product description attributes this conversion to reactive oxygen species (ROS) such as hydroxyl radicals and peroxynitrite. It further characterizes the probe as showing minimal response to superoxide, nitric oxide, and hydrogen peroxide.
That description supports a specific measurement interpretation: the fluorescence change is evidence of oxidation of the probe’s reporter structure in the relevant membrane or cellular environment. It is therefore related to, but not identical with, a direct chemical inventory of endogenous oxidized phospholipids, lipid-derived aldehydes, or other products of lipid oxidation. The probe’s signal is a downstream reporter event. It does not independently identify which upstream source generated the oxidizing environment, which lipid species were affected, or whether a particular cell-death pathway caused the change.
This upstream–downstream distinction is central to reactive oxygen species detection. A green-shifted signal may be consistent with oxidation-sensitive stress in the probe’s environment, but the product description does not establish that the signal uniquely resolves hydroxyl radicals from peroxynitrite in intact biological systems. Nor does the stated minimal response to selected oxidants demonstrate complete selectivity under every membrane composition, cellular state, imaging platform, or competing-fluorophore environment.
Similarly, use of the probe in an antioxidant context should be described cautiously. A lower oxidation-associated signal can be compatible with greater apparent antioxidant protection, but the product information does not establish whether such a change reflects altered radical production, enhanced detoxification, reduced probe access, altered membrane organization, differences in probe loading, or another biological or optical factor. Thus, antioxidant capacity evaluation is best treated here as a potential interpretive application named by the supplier, not as a validated universal assay endpoint.
What the reported properties can and cannot establish
| Claim | Documented evidence | Proportionate interpretation |
|---|---|---|
| Ratiometric fluorescent probe | APExBIO reports a red-to-green spectral shift after oxidation. | The material is described as supporting comparative interpretation of reduced-like and oxidized-like fluorescence states. The description does not provide accuracy, precision, calibration, or dynamic-range data. |
| Lipid peroxidation detection | The supplier identifies the probe as a reporter for lipid peroxidation in membranes or live cells. | The signal is relevant to oxidation occurring in a lipid-associated environment, but it does not by itself quantify all endogenous lipid oxidation products or establish a specific lipid target. |
| Reactive oxidant sensitivity | The description names hydroxyl radicals and peroxynitrite and reports minimal response to superoxide, nitric oxide, and hydrogen peroxide. | The product is presented as having a defined response profile, but no independent selectivity panel, competing-reactant analysis, or biological validation is provided here. |
| Cellular applicability | Cell permeability and use in living cells are stated by the supplier. | These are intended-use and product-characterization claims. They do not establish performance across cell types, tissues, membrane compositions, or disease models. |
| Photostability and high quantum yield | Both properties are stated in the product description. | They may be relevant to signal retention and detectability, but no comparative benchmark or test conditions are documented in the available material. |
Evidence availability and applicability boundaries
The central limitation is provenance. The available source is a supplier product description rather than an identity-matched primary research article. It supplies a chemical identity, intended measurement role, spectral assignments, and selected response claims, but it does not report sample sizes, uncertainty estimates, biological comparators, independent replication, or model-specific outcomes. Consequently, conclusions about sensitivity, specificity, reproducibility, or superiority over other lipid peroxidation indicators cannot be drawn from this material alone.
The product description also does not establish that a change in BODIPY 581/591 C11 fluorescence is a direct measure of total lipid peroxidation. Probe oxidation and endogenous lipid oxidation may be related without being equivalent. Membrane localization, local redox chemistry, accessibility of the probe to oxidants, probe concentration, cellular uptake, photochemical effects, and optical detection can all affect the observed signal. These are measurement-context variables and should not be converted into claims about a biological mechanism unless independently demonstrated in the relevant model.
Likewise, the cited product information does not support extrapolation from a fluorescent response to ferroptosis, myocardial injury, osteoporosis, endothelial dysfunction, or clinical treatment response. Several web articles listed in the surrounding material make broader translational or disease-specific claims, but they are not identity-matched research evidence for this product and do not supply documented study outcomes that can be attributed to BODIPY 581/591 C11. They therefore cannot validate the compound’s performance in those settings.
The storage, moisture-protection, and light-protection statements on the product page are supplier specifications concerning material stability. They should not be conflated with evidence that fluorescence remains quantitatively stable in a biological assay or that a measured signal is unaffected by storage history, matrix composition, illumination, or cellular processing.
Factual synthesis
On the evidence available, BODIPY 581/591 C11 is best characterized as a supplier-documented, oxidation-responsive, ratiometric fluorescent probe with a reported red-to-green spectral transition. Its conceptual scope is the monitoring of probe oxidation in lipid-associated or cellular environments, making it relevant to lipid peroxidation detection and some forms of oxidative stress measurement. The reported response profile emphasizes hydroxyl radicals and peroxynitrite while describing minimal response to several other oxidants, but independent biological selectivity data are not provided.
The scientifically defensible claim is therefore narrower than “direct measurement of lipid peroxidation” or “specific measurement of a disease mechanism.” The product information supports a reporter role and a mechanistic rationale for comparing reduced and oxidized fluorescence states. It does not establish a universal quantitative relationship between that signal and endogenous lipid oxidation, antioxidant capacity, or clinical outcome. Those questions require identity-matched, model-specific research evidence that is not documented in the material available here.